**Author details**

Ewa Dudzińska Medical University of Lublin, Poland

\*Address all correspondence to: ewadudzinska@umlub.pl

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**49**

*Single-Nucleotide Polymorphisms in Inflammatory Bowel Disease*

Medicine. 2017;**33**(1):82-88. DOI:

[9] Lee A, Kanuri N, Zhang Y, et al. IDO1 and IDO2 non-synonymous gene variants: Correlation with crohn's disease risk and clinical phenotype.

[10] Kennedy NA, Lamb CA, Berry SH, Walker AW, Mansfield J, Parkes M, et al. The impact of NOD2 variants on fecal microbiota in Crohn's disease and controls without gastrointestinal disease. Inflammatory Bowel Diseases. 2018;**24**(3):583-592. DOI: 10.1093/ibd/

[11] Meddens CA, van der List ACJ, Nieuwenhuis EES, Mokry M. Noncoding DNA in IBD: From sequence variation in DNA regulatory elements to novel therapeutic potential. Gut.

Kenison JE, Yeste A, Murugaiyan G, Sambanthamoorthy S, et al. AHR activation is protective against colitis driven by T cells in humanized mice. Cell Reports. 2016;**17**(5):1318-1329. DOI:

10.1159/000458006

PLoS One. 2014;**9**:115848

izx061

2019;**68**:928-941

[12] Goettel JA, Gandhi R,

10.1016/j.celrep.2016.09.082

[13] Bosca-Watts MM, Tosca J,

or no bug. World Journal of Gastrointestinal Pathophysiology.

2015;**6**(1):1-12

10.1155/2018/6914346

Anton R, Mora M, Minguez M, Mora F. Pathogenesis of Crohn's disease: Bug

[14] Dudzińska E, Gryzinska M, Kocki J. Single nucleotide polymorphisms in selected genes in inflammatory bowel disease. BioMed Research

International. 2018;**2018**:6914346. DOI:

[15] Iida T, Onodera K, Nakase H. Role of autophagy in the pathogenesis of inflammatory bowel disease. World Journal of Gastroenterology.

*DOI: http://dx.doi.org/10.5772/intechopen.92051*

[1] Vezza T, Rodríguez-Nogales A, Algieri F, et al. Flavonoids in

inflammatory bowel disease: A review.

[2] Etienne-Mesmin L, Chassaing B, Gewirtz AT. Tryptophan: A gut microbiota-derived metabolites

[3] Lan D, Niu J, Miao J, Dong X, Wang H, Yang G, et al. Expression of guanylate cyclase-C, guanylin, and uroguanylin is downregulated proportionally to the ulcerative colitis disease activity index. Scientific Reports. 2016;**6**:25034. DOI: 10.1038/

[4] Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG Clinical Guideline: Ulcerative colitis in adults. The American Journal of Gastroenterology. 2019;**114**(3):384-413. DOI: 10.14309/ajg.0000000000000152

[5] Agouridis AP, Elisaf M, Milionis HJ. An overview of lipid abnormalities in patients with inflammatory bowel disease. Annals of Gastroenterology.

[6] Mahdi BM. Role of HLA typing on Crohn's disease pathogenesis. Annals of Medicine and Surgery. 2015;**4**:248-253

Gil-Kulik P, Chomik P, Świstowska M, Gryzińska M, et al. Imbalance of controlled death in peripheral blood lymphocytes in Crohn's disease and ulcerative colitis. Medicina (Kaunas, Lithuania). 2019;**55**(6):231. DOI: 10.3390/medicina55060231

[8] Atreya R, Neurath MF. Current and future targets for mucosal healing in inflammatory bowel disease. Visceral

[7] Dudzińska E, Szymona K,

regulating inflammation. World Journal of Gastrointestinal Pharmacology and Therapeutics. 2017;**8**(1):7-9. DOI:

**References**

Nutrients. 2016;**8**:211

10.4292/wjgpt.v8.i1.7

srep25034

2011;**24**(3):181-187

*Single-Nucleotide Polymorphisms in Inflammatory Bowel Disease DOI: http://dx.doi.org/10.5772/intechopen.92051*
